Source 1primary paper2026MED
Toolkit/LANA immunostaining
LANA immunostaining
Also known as: LANA staining
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
While histopathology and LANA staining remain diagnostic standards... Current diagnosis of KS still relies primarily on histopathology and LANA immunostaining, which remain the gold standard
Usefulness & Problems
Why this is useful
LANA immunostaining is presented as a current gold-standard diagnostic method for KS alongside histopathology. It is used to support diagnosis of KSHV-associated lesions.; diagnosis of Kaposi's sarcoma; standard diagnostic assessment of KSHV-associated lesions
Source:
LANA immunostaining is presented as a current gold-standard diagnostic method for KS alongside histopathology. It is used to support diagnosis of KSHV-associated lesions.
Source:
diagnosis of Kaposi's sarcoma
Source:
standard diagnostic assessment of KSHV-associated lesions
Problem solved
It addresses routine diagnosis of KS and related KSHV-associated pathology assessment.; provides a current diagnostic standard for KS evaluation
Source:
It addresses routine diagnosis of KS and related KSHV-associated pathology assessment.
Source:
provides a current diagnostic standard for KS evaluation
Problem links
provides a current diagnostic standard for KS evaluation
LiteratureIt addresses routine diagnosis of KS and related KSHV-associated pathology assessment.
Source:
It addresses routine diagnosis of KS and related KSHV-associated pathology assessment.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
immunostainingTechniques
Functional AssayTarget processes
diagnosticImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The abstract places LANA immunostaining within a histopathology workflow, implying tissue-based pathological assessment is required.; used within histopathology-based diagnostic workflows
The abstract states that it has important limitations in early or atypical lesions and in distinguishing latent from lytic infection.; important limitations in early or atypical lesions; limitations in distinguishing latent from lytic infection
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
KSHV-associated malignancies lack virus-specific targeted treatments and current clinical outcomes remain suboptimal, especially in immunocompromised patients.
LANA immunostaining and histopathology have important limitations in early or atypical lesions and in distinguishing latent from lytic infection.
Histopathology and LANA immunostaining remain the diagnostic standard and gold standard for current KS diagnosis.
CRISPR-Cas9 is presented as a next-generation approach that aims to inhibit viral replication, modulate oncogenic pathways, and enhance immune responses in KSHV-associated disease.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug lana-immunostaining
While histopathology and LANA staining remain diagnostic standards... Current diagnosis of KS still relies primarily on histopathology and LANA immunostaining, which remain the gold standard
Source:
diagnostic limitationsupports
LANA immunostaining and histopathology have important limitations in early or atypical lesions and in distinguishing latent from lytic infection.
Source:
diagnostic standardsupports
Histopathology and LANA immunostaining remain the diagnostic standard and gold standard for current KS diagnosis.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Source:
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Source-backed strengths
described as a diagnostic standard; described as part of the gold standard for current KS diagnosis
Source:
described as a diagnostic standard
Source:
described as part of the gold standard for current KS diagnosis
Compared with imaging
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Shared frame: source-stated alternative in extracted literature
Strengths here: described as a diagnostic standard; described as part of the gold standard for current KS diagnosis.
Relative tradeoffs: important limitations in early or atypical lesions; limitations in distinguishing latent from lytic infection.
Source:
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Compared with imaging surveillance
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Shared frame: source-stated alternative in extracted literature
Strengths here: described as a diagnostic standard; described as part of the gold standard for current KS diagnosis.
Relative tradeoffs: important limitations in early or atypical lesions; limitations in distinguishing latent from lytic infection.
Source:
The abstract contrasts it with emerging technologies including advanced imaging and new molecular biomarkers such as viral microRNAs.
Ranked Citations
- 1.